Listen Now
Topics Covered
- Overview and Definition of Diagnostic Technologies for Small Cell Lung Cancer (SCLC)
- How Diagnostic Technologies Work
- Examples of How Diagnostic Technologies Inform the Treatment of Small Cell Lung Cancer
- Understanding the FDA’s Accelerated Approval Program: How it Increases Your Treatment Options
- Combination Systemic Treatment for Metastatic Small Cell Lung Cancer
- Diagnostic Technologies, Targeted Therapies & Precision Medicine
- The Role of the Pathologist
- Clinical Trials: How Diagnostic Technology Research Contributes to Treatment Choices
- The Benefits of Combination Therapy in the Treatment of People Living with Small Cell Lung Cancer
- Talking with Your Healthcare Team about the Most Current Treatment Choices for Small Cell Lung Cancer & Quality-of-Life Issues
- Questions for Our Panel of Experts
Our Panel of Experts

Misty Shields, MD, PhD
Assistant Professor of Clinical Medicine, Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Associate Member, Experimental and Developmental Therapeutics, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Brian S. Henick, MD
Director of Translational Research, Upper Aero-digestive Cancers in Medical Oncology, Associate Director, Experimental Therapeutics, Assistant Professor of Medicine at CUIMC, Thoracic Oncology, Herbert Irving Comprehensive Cancer Center

Benjamin J. Swanson, MD, PhD
Associate Professor of Pathology & Microbiology, Surgical Pathologist Specializing in Lung, Head & Neck in GI Diseases, University of Nebraska Medical Center

Ann Fish-Steagall, RN, BSN
Senior Vice President, Patient Services and Health Care Delivery, LUNGevity Foundation®

Charlotte Ference, MSW
Lung Cancer Coordinator, CancerCare

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on June 13, 2023.